Agonists |
Cat. No. | Product Name / Activity |
---|---|
1445 | N-Arachidonylglycine |
GPR18 agonist; endocannabinoid | |
Antagonists |
Cat. No. | Product Name / Activity |
6372 | PSB CB5 |
Selective GPR18 antagonist | |
Inhibitors |
Cat. No. | Product Name / Activity |
1462 | AACOCF3 |
FAAH inhibitor | |
3381 | AM 1172 |
FAAH inhibitor; also anandamide uptake inhibitor and CB receptor partial agonist | |
3262 | JNJ 1661010 |
Selective, reversible FAAH inhibitor | |
4715 | JZL 195 |
Dual FAAH and MAGL inhibitor | |
2452 | LY 2183240 |
FAAH inhibitor; also inhibits anandamide uptake | |
1815 | Palmitoylisopropylamide |
Inhibitor of FAAH | |
4175 | PF 3845 |
Selective FAAH inhibitor | |
3307 | PF 750 |
Selective FAAH inhibitor | |
4785 | SA 47 |
Selective FAAH inhibitor | |
4752 | SA 57 |
Potent FAAH inhibitor | |
5209 | TAK 21d |
Potent FAAH inhibitor | |
4355 | TC-F 2 |
Potent, reversible and selective FAAH inhibitor | |
4612 | URB 597 |
Potent and selective FAAH inhibitor | |
3252 | WWL 70 |
Potent ABHD6 inhibitor | |
Other |
Cat. No. | Product Name / Activity |
2836 | Arachidonyl serotonin |
Dual FAAH inhibitor/TRPV1 antagonist | |
1814 | N-ArachidonylGABA |
Inhibits pain in vivo | |
2288 | O-1918 |
Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor | |
0879 | Palmitoylethanolamide |
FAAH and PAA substrate. Selective GPR55 agonist | |
2206 | 2-Palmitoylglycerol |
Endogenous lipid; enhances activity of 2-arachidonylglycerol (Cat. No. 1298) |